REKA Company Description

Rekah Pharmaceutical Industry Ltd. engages in the manufacture, marketing, sale, and distribution of prescription and OTC drugs, dermo-cosmetics, vitamins, and nutritional supplements in Israel.

The company offers steroid tablets; antibiotics, including penicillin and cephalosporin; drops and ointments to treat allergies, infections, and dryness of the eyes; baby products; and dermatological preparations.

Its portfolio of products comprise approximately 280 drugs used in various medical fields. Rekah Pharmaceutical Industry Ltd. was founded in 1941 and is based in Holon, Israel.

Rekah Pharmaceutical Industry Ltd.

Country	Israel
Founded	1941
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	427
CEO	Mordechai Elgrabli

Contact Details

Address: 30 Hamelach Street Holon, 5881904 Israel
Phone	972 3 558 1233
Website	rekah.co.il

Stock Details

Ticker Symbol	REKA
Exchange	Tel Aviv Stock Exchange
Fiscal Year	January - December
Reporting Currency	ILS
ISIN Number	IL0010810096
SIC Code	2834

Key Executives

Name	Position
Yaakov Elgrabli	Chief Executive Officer of Ophir and Shalpharm Ltd
Yuval Elgrabli	Deputy Chief Executive Officer and Director of Business Development
Nir Sella	Chief Executive Officer - Fresh of Life Pharma Ltd.
Jacob Elgrably	Chief Executive Officer of Ophir Shalpharm
Mordechai Elgrabli	Chief Executive Officer and Director
Georgette Elgrabli	Director of Industrial Division and Director
Meir Melumad	Director of Operations